NCT06989671: SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC
- State
- Not started
- Phase
- Phase 2
- People
- 430 planned
- Started
- 30 Aug 2025
- Primary completion
- 30 Dec 2027
- Arms
- JMT101 monotherapy
- Results
- None posted
- 25 May 2025: Trial registered